0001179110-20-008422.txt : 20200723 0001179110-20-008422.hdr.sgml : 20200723 20200723160748 ACCESSION NUMBER: 0001179110-20-008422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200721 FILED AS OF DATE: 20200723 DATE AS OF CHANGE: 20200723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arroyo Santiago CENTRAL INDEX KEY: 0001706857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 201043742 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS, INC. STREET 2: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-07-21 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001706857 Arroyo Santiago C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, Chief Medical Officer Common Stock 2020-07-21 4 A 0 10156 12.76 A 38935 D Common Stock 2020-07-21 4 A 0 22500 17.20 A 61435 D Common Stock 2020-07-21 4 S 0 49967 34.62 D 11468 D Common Stock 2020-07-22 4 S 0 1939 32.32 D 9529 D Stock Option (Right to Buy) 12.76 2020-07-21 4 M 0 10156 0 D 2020-02-11 2029-02-11 Common Stock 10156 94014 D Stock Option (Right to Buy) 17.20 2020-07-21 4 M 0 22500 0 D 2018-12-20 2027-06-20 Common Stock 22500 81748 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $34.23 to $35.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This transaction was executed in multiple trades at prices ranging from $31.33 to $34.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ R. Mark Chamberlin as attorney in fact 2020-07-23